Prasugrel Tablet, Film Coated
Product Images NDC 43817-239

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Prasugrel (NDC 43817-239). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Panacea Biotec Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

29da9cfc 814c 448a Afc2 F7c7ccd518b5 01

Chemical structure of prasugrel, showing its molecular arrangement including functional groups and atoms relevant to its pharmacological activity.*

FDA Label Image

29da9cfc 814c 448a Afc2 F7c7ccd518b5 02

A line graph comparing Non-CABG-Related TIMI Major or Minor Bleeding Events (%) over Days from Randomization between Prasugrel Tablets and Clopidogrel. The y-axis shows percentage of bleeding events from 0 to 5%, and the x-axis shows days up to 450. Prasugrel Tablets show a higher cumulative incidence of bleeding events than Clopidogrel over time. A smaller inset graph shows the same comparison over a shorter period up to 7 days. Numbers at risk for each treatment group are listed below the x-axis.*

FDA Label Image

29da9cfc 814c 448a Afc2 F7c7ccd518b5 03

A line graph depicting the inhibition of platelet aggregation (%) over time (hours) with data points showing mean inhibition plus standard deviation at various time intervals up to 24 hours. The study condition involves 20 µM ADP as the agonist for platelet aggregation.*

FDA Label Image

29da9cfc 814c 448a Afc2 F7c7ccd518b5 04

A line graph comparing cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke rates over time between Prasugrel tablets and Clopidogrel in UA/NSTEMI patients. The graph plots percentage events on the y-axis against days from randomization on the x-axis, showing lower event rates for Prasugrel. An inset graph expands early time points with similar trend and p-values indicating statistical significance.*

FDA Label Image

29da9cfc 814c 448a Afc2 F7c7ccd518b5 05

A line graph comparing cardiovascular death, nonfatal myocardial infarction (MI), or nonfatal stroke percentages over days from randomization between Prasugrel tablets and Clopidogrel in STEMI patients, including a zoomed inset for the first 7 days. The graph shows statistical significance values (p=0.02 and p=0.008).*

FDA Label Image

29da9cfc 814c 448a Afc2 F7c7ccd518b5 06

A forest plot comparing the percent events and hazard ratios of Prasugrel Tablets versus Clopidogrel across various baseline characteristics in a patient population, including age, gender, body weight, region, diabetes mellitus, metabolic syndrome, prior medical history, symptom onset time, stent type, and GP IIb/IIIa inhibitor use. The horizontal axis represents the hazard ratio, where values less than 1 favor Prasugrel and values greater than 1 favor Clopidogrel.*

FDA Label Image

29da9cfc 814c 448a Afc2 F7c7ccd518b5 07

A forest plot showing baseline characteristics and percent event comparisons between Prasugrel Tablets and Clopidogrel across multiple subgroups, including age, gender, body weight, region, diabetes, metabolic syndrome, previous medical history, time from symptom onset, stent type, and inhibitor use. The hazard ratio scale indicates which drug performs better.*

FDA Label Image

29da9cfc 814c 448a Afc2 F7c7ccd518b5 08

Prasugrel Tablets 5 mg film-coated oral tablets, container label for 30 tablets by Panacea Biotec Limited. The label includes the NDC 43817-239-01, storage instructions, manufacturer details, and a depiction of a round tablet imprinted with '5'. The label states 'Rx only' and advises to dispense and keep in the original container with desiccant.*

FDA Label Image

29da9cfc 814c 448a Afc2 F7c7ccd518b5 09

Prasugrel Tablets 10 mg film-coated oral tablets, bottle containing 30 tablets. Label includes dosage strength, NDC 43817-240-01, Panacea Biotec Limited as labeler, storage instructions, lot and expiration date fields, and a warning about tamper-evident seal. The label features a small image of the round brown tablet marked "10."*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.